Results 71 to 80 of about 2,740,550 (314)

EVALUATION OF PUBLIC GOODS -THE COUNTERPOINTS AND CONTRADICTIONS OF THE CROATIAN CONCEPT OF ‘GOODS OF INTEREST TO THE REPUBLIC OF CROATIA’

open access: yesZbornik Radova Pravnog Fakulteta u Splitu, 2009
In this paper the author analyses the dominant concept about ‘public things’ and in particular the question of the nature of public property. Also analysed are the viewpoints which see goods in public property as some kind of private property.
Branko Babac
doaj  

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

open access: yesMolecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor   +2 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Privacy, Property, and Publicity

open access: yesSSRN Electronic Journal, 2018
Review of Jennifer E. Rothman's The Right of Publicity: Privacy Reimagined for a Public World.
openaire   +2 more sources

Public policy and property-liability insurance [PDF]

open access: yes
Insurance industry ; Public ...
Scott E. Harrington
core  

Molecular cancer prevention: Intercepting disease

open access: yesMolecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco   +2 more
wiley   +1 more source

Legal problems of leasing federal real estate assigned to state enterprises and budgetary institutions

open access: yesЮридический вестник Самарского университета
The efficiency of using publicly owned real estate remains a pressing legal issue. It is assumed that the optimal extraction of all useful properties from public real estate is possible, including by attracting the widest possible range of persons to use
A. A. Maksurov
doaj   +1 more source

MEASURING INTERACTIONS AMONG URBAN DEVELOPMENT, LAND USE REGULATIONS, AND PUBLIC FINANCE [PDF]

open access: yes
In this paper, a theoretical model is developed to analyze the interactions among residential development, land use regulations, and public financial impacts (public expenditure and property tax).
Cho, Seong-Hoon, Wu, JunJie
core   +1 more source

Enriching Discourse on Public Domains [PDF]

open access: yes, 2006
Is there one public domain, or are there many public domains? The scholarly literature predominantly assumes there is only one, for references abound to “the public domain” in the singular.
Samuelson, Pamela
core   +2 more sources

Home - About - Disclaimer - Privacy